All Posters

For any questions regarding posters, please email

Poster session 1
Sunday 16 September 2018 - 12:30 to 14:00

Individual patient data as a key modifier of Cochrane Review results: the SPS3 trial case 101
Comparing adverse events data from systematic reviews and consumer social media posts 102
Defining ranges for certainty ratings of diagnostic accuracy 103
The first ten years of Cochrane DTA reviews: progress and common methodological challenges 104
The reporting quality of systematic reviews and meta-analysis of diagnostic test accuracy published in high impact factor journals, based on the PRISMA-DTA statement 105
The effects of correlation between the test positive rate and prevalence on tailored meta-analysis 107
Meta-analyses of diagnostic accuracy in imaging journals: analysis of pooling techniques and their effect on summary estimates of diagnostic accuracy 108
Methods to facilitate the interpretation of pooled diagnostic test accuracy estimates by means of selecting a representative pre-test probability 110
Evaluation of baseline adherence to the PRISMA-DTA reporting guideline 111
From registration to publication of systematic review protocols: changes over time 112
Are retracted studies affecting our reviews? 114
Withdrawals of Cochrane systematic reviews: a description of reasons 115
Verification of conflicts of interest disclosures in health research: a conceptual analysis 116
The reporting of funding in health policy and systems research: a cross-sectional study 117
Discussion section of Cochrane Reviews: is it supported by systematic reviews? 118
When methodologies conflict: developing tools to compare and select appropriate methodologies for conducting, and appraising evidence from systematic reviews 119
Evidence-based medicine: how we teach medical undergraduates 120
Evidence-based medicine in medical school: how to learn about evidence in an intensive care unit? 121
Local capacity for quality evidence syntheses: methodological and reporting quality of systematic reviews from Dalhousie University-affiliated reviewers 122
A blog series by Students 4 Best Evidence: to explain and promote 36 ‘key concepts’ essential for assessing treatment claims 123
Teaching medical students how to elaborate search strategies and find the best evidence 125
Achieving saturation in qualitative analysis: developing a codebook for a study on peer review in biomedical journals 126
Multiple strategy peer-taught evidence-based medicine course in a poor-resource setting 127
EBM and research methodology education programs - how and when to teach: local experience at University of Valparaiso Medical School, Chile 128
A systematic review of how studies describe digital health educational interventions: stage one of the development of the STEDI guideline 129
Training new commissioners from the social/welfare area 130
Implementation of the evidence-based health discipline in the Professional Master's Program of Health State Government Department, Federal District, Brazil 131
Evidence-based healthcare contents in the undergraduate curriculum of health careers in Chilean universities 132
Initiatives to successfully improve the acceptance of evidence-based practice in an aid organisation: the example of the Belgian Red Cross 133
A nationwide survey of the attitudes of doctors and dentists in training towards use of evidence-based practice 134
Teaching Brazilian journalism students about evidence-based health care: preliminary results of a randomized trial 135
Mentoring to make a difference: it takes a village to raise a systematic review (for implementation in policy or practice) 136
Evaluation of the impact of evidence-based health care education for Chinese medicine practitioners 137
A practical toolkit for clinicians to locate best evidence to improve patient outcomes 138
Education efforts towards patients' knowledge and attitudes regarding clinical research: a mixed methods pilot study 139
Social media for dissemination of Cochrane evidence in Polish and creating engagement opportunities 140
The Sex and Gender Appraisal Tool for Systematic Reviews (SGAT-SR): user experience with 113 Cochrane Reviews 141
Patient and partners' reported outcomes in sexual dysfunction 142
Tackling social exclusion and inequalities: barriers to accessing health- perspectives from a 'community of practice' working with migrants in Thailand 143
How health equity characteristics were reported in Chinese clinical practice guidelines 146
The judicialisation of health in Brazil: a huge challenge that calls for innovative solutions 147
Evidence for rare diseases is available, but poses challenges to synthesis: a case study 148
Advantages and challenges of including randomised and non-randomised evidence in a systematic review: example of advanced or metastatic renal cell carcinoma 149
Inclusion of studies and statistics in meta-analysis: a comparison between Cochrane and systematic reviews from other high impact factor journals 150
Definition of eligibility for non-randomised studies in 113 Cochrane Reviews of interventions to prevent healthcare-associated infections 151
A methodological research of non randomized controlled trials in network meta analysis 152
Unique methodological challenges to incorporating studies on food taxation into Cochrane Reviews: comparing Cochrane EPOC and Reeves et al 2017 study design classifications 154
Taking evidence synthesis beyond its traditional role: a ‘rigorous speculation’ framework for predicting success of innovative treatments with early evidence bases 155
Methodologies for critical appraisal of prevalence studies: a systematic review 156
Methodological characteristics of systematic reviews of prevalence 157
Transparent assessment of resource use and costs of randomised clinical trials: a case series 158
Clinical experts are an important resource in systematic reviews of the epidemiology of rare diseases 159
Developing the updating strategy for the European Breast Guidelines within the European Commission Initiative on Breast Cancer 160
USDA Nutrition Evidence Library: producing systematic reviews to support evidence-based federal nutrition guidance and programs in the USA 161
Overcoming the difficulties of meta-analysis in psychotherapy 162
Growing the North West Coast Cochrane Support Network 163
The top clinical research priorities in mental health: implementation and maintainance of a website with free access for researchers, academics, health professionals and consumers in Brazil 164
Bringing a systematic element to complex focussed literature reviews 165
Citation bias in imaging research: are studies with higher diagnostic accuracy estimates cited more often? 166
Appraising the quality of evidence in age estimation studies: a systematic review 167
Exploring the magnitude of verification bias in diagnostic accuracy studies 168
Agreements about risk of bias in randomized controlled trials on different interdental cleaning aids 169
CONSORT for Abstract reporting items by subscription and open access (OA) journals 170
Supporting clinical trial registration and reporting requirements at academic organizations in the USA 171
Examining reporting bias in randomized controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications 172
The risk of bias in Iranian randomized controlled trials included in Cochrane Reviews 173
Investigating risk of bias: special considerations for test-treatment interventions 175
Are results from clinical study registers considered in recent interventional Cochrane Reviews? A systematic review 177
Minimising the impact of reporting bias by using data from clinical study reports for the determining the drop-out rates in antidepressant trials 178
Comparison of outcome reporting in clinical study reports, journal publications and registry reports in the field of telecardiology 179
Survey of investigators in the Australian and New Zealand Clinical Trial Register: did they publish? If not why not? 180
Experience in using ROBINS-I for the assessment of controlled before-after studies 181
Validation of the Spanish version of the Risk of Bias in Systematic Reviews (ROBIS) tool 185
Reporting bias: higher diagnostic accuracy is linked to faster publication in imaging research 186
Reporting bias in imaging research: association of diagnostic accuracy estimates in radiology conference abstracts with full-text publication 187
Comparison of the Academy of Nutrition and Dietetics updated Quality Criteria Checklist and Cochrane's ROB 2.0 as risk of bias tools 188
Determining the degree of dissemination bias for health-related quality of life outcomes in antidepressant trials 189
How is the timing of clinical trial registration related to clinical trial characteristics and risk of bias? 190
Results of an online survey evaluating reasons for retrospective trial registration and mechanisms to increase prospective registration compliance 191
Setting up a national translation initiative for Malay: ideas, challenges and future directions 192

Poster session 2
Monday 17 September 2018 - 12:30 to 14:00

Survey among Spanish doctors about worldwide initiatives aiming to reduce low-value health practices and their diagnostic recommendations 201
Updating the evidence for German geriatric medicine: an approach inspired by Cochrane Living Systematic Reviews 202
The development of IN SUM: a database of systematic reviews on effects of child mental health and welfare interventions 203
Using a figure to display characteristics of studies in reviews of complex interventions or reviews with broad questions 205
Discovering the voice of the Cochrane Library customer 206
Trial publication after registration in Clinical Trials Registry of India (CTRI): a cross-sectional analysis of randomized controlled trials 207
A review of methods used for hazard identification and risk assessment of environmental hazards 208
Cochrane Brazil Facebook: reaching people through social media 209
Readability assessment of plain language summaries in Cochrane diagnostic test accuracy reviews 210
The gap between currently available evidence and awareness of wound care in clinical practice: it is time to shower earlier 211
Academic detailing as a strategy to implement a HIV guideline in primary health care 212
Cochrane highlights: disseminating Cochrane Reviews through a Brazilian international open access journal 213
Authorship in reports of clinical practice guidelines: a systematic cross-sectional analysis 214
Cochrane Germany Foundation: activities directed at and in co-operation with healthcare professionals 215
Tackling barriers to the use of trusted evidence for informing clinical practice: the German 'Cochrane for Physiotherapy!' resources 216
The effectiveness of Students 4 Best Evidence as a tool to improve evidence-based practice competencies in undergraduate health professional students: a pilot study 217
Medical students learning of reporting guidelines based on the EQUATOR Network 218
Cochrane Reviews are not a direct source of information for Swiss physicians 219
Measuring impact, assessing priorities and delivering high-quality timely reviews to improve patient health outcomes 220
Descriptive analysis of the first 1000 trials in Pan African Clinical Trial Registry (PACTR) 221
Comparison of RIGHT and AGREE reporting checklists for healthcare practice guidelines 222
All that glitters is not gold: predatory journals may be open access, but not openly accessible 223
Coerced medication in mental health care – what matters to patients? 224
The current situation in Cochrane Reviews using GRADE: a cross-sectional study 225
How a systematic review and continued stakeholder engagement can lead to a theory of change relevant to the aid sector 227
Rehabilitation interventions in randomized controlled trials for low back pain: are they statistically significant and clinically relevant? 228
Encouraging the use of EQUATOR Network reporting guidelines in Brazil 229
Lessons learned from descriptions and evaluations of knowledge-translation platforms supporting evidence-informed policymaking in low- and middle-income countries: a systematic review 230
Reporting, presentation and wording of recommendations in clinical practice guidelines 231
Evaluating people’s ability to assess treatment claims: validation of a test in Mandarin developed from the Claim Evaluation Tools database 232
Improving Field Knowledge Translation through exchange with users 233
Mapping tuberculosis treatment intervention trials in Africa 236
Collect meaningful surgical data using an off-line application 237
Completeness of reporting of rapid reviews of primary studies according to journal publication status using PRISMA and PRISMA for Abstracts 238
Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: a methodological survey 239
Effectiveness of strategies to reduce low-value care: a systematic review of de-implementation studies 240
Quality of reporting web-based and non-web-based survey studies: what authors, reviewers and consumers should consider 241
Software tools to support network development in network meta-analysis: a feature analysis 243
The reporting of guideline dissemination and implementation in WHO guidelines 244
The impact of low back pain clinical trials measured by the Altmetric score: cross-sectional study 245
Delphi Method and Analytic Hierarchy Process to establish an indicator system to evaluate rational drug use in children with primary nephrotic syndrome 246
How many meta-analyses of surgery searched grey literature, is it helpful? A cross-sectional analysis of robot-assisted versus traditional surgery 247
Reporting characteristics of health policy briefs: a cross-sectional study of briefs in HSE and WHO databases 249
Schizophrenia trials in Mexico: are we producing our own evidence? 250
Conclusiveness of the Cochrane reviews in physiotherapy: a systematic analysis 251
The publishing characteristics of Cochrane Reviews of dentistry and oral health by Chinese researchers 252
Usage and acceptance of adjusted indirect comparisons in IQWiG reports in the period 2011 to 2016 253
Waste in research? Exploring overlaps in systematic reviews on exercise for depression in children and adolescents 254
The proportion of articles behind paywalls – a barrier to patient access? 255
Review authors' views of the PRISMA statement 256
Global production of systematic reviews on population health issues in the Middle East and North Africa: preliminary results of a systematic overview and bibliometric analysis 257
Advancing research integrity: a programme to embed good practice in Africa 258
A survey on the methodology of nursing clinical practice guidelines in the National Guideline Clearinghouse 259
The current landscape of prospectively planned meta-analyses in health research 260
Is health information from TV medical talk shows supported by evidence? 261
Extending treatment ranking in network meta-analysis to account for clinical experience on treatment performance and credibility of the evidence 262
The number needed to treat in pairwise and network meta-analysis and its graphical representation 263
The methodology and reporting characteristics of Campbell reviews: a review 264
Development of workable solutions to overcome known limitations of overview methodology 265
Managing overlap in overviews of reviews: a cross-sectional survey of the published literature between 2015 and 2017 266
The quality of systematic reviews/meta-analyses published in the field of bariatrics: a cross-sectional systematic survey 267
Assessment of the completeness of reporting of methods in overviews of systematic reviews 268
Is the transitivity assumption valid? 269
A overview of systematic reviews about patients' values and preferences with AMSTAR II 270
How many network meta-analyses were adopted by clinical practice guidelines? A cross-sectional survey 271
Epidemiology of systematic reviews in imaging journals 272
Assessing the certainty of evidence in overviews of reviews: current practice and expert perspectives 273
Descriptive analysis of non-randomized studies included in Cochrane Reviews regarding their availability in PubMed 274
Development of a questionnaire measuring individual goals of health information seeking (GAINS) 275
Better, faster, stronger: how to find tools to expedite the systematic review process 276
Utility of machine learning to identify research for updating a systematic map of evaluations of public health interventions within community pharmacies 277
SCOOPS versus PICO: testing a new framework for describing reviews of implementation research in healthcare 278
Are the search and data extraction procedures similar between Cochrane Reviews and systematic reviews from other high impact factor journals? 279
Overlapping of indexed trials and systematic reviews over time among Embase, PubMed, Cochrane Library and LILACS 280
Handsearching and description of controlled clinical trials in Spanish language dental journals 281
Identifying national and sub-national data of maternal cause of death: challenges in epidemiologic searching of bibliographic databases 282
Handsearching and descriptive analysis of controlled clinical trials published in neurology biomedical journals in Spain 283
Annotating Cochrane systematic reviews of interventions 284
Description of trials and systematic reviews exclusively retrieved by LILACS 285
Barriers and facilitators to sharing of individual patient data: a randomised controlled trial 286
Design and validation of a search filter for LGBTQ+ populations 287
A search strategy for retrieving articles from the LILACS database in a systematic review of diagnostic accuracy studies: an experimental study 288
How detailed is the reporting of web searching to identify studies for inclusion in Cochrane Reviews? 289
What if EPOC reviews only included studies from MEDLINE? 290
Search strategies for clinical guidelines vary in guideline development handbooks 291
PICO annotation of intervention reviews: how to get it done! A case study of Cochrane Airways 292
An experience of producing a group of diagnostic test accuracy reviews on the diagnosis and staging of skin cancer 293

Poster session 3
Tuesday 18 September 2018 - 12:30 to 14:00

Optimising stakeholder engagement for informing direction and scope of a programme of Cochrane Reviews on hip fracture management 301
Identifying existing models of public and patient involvement in palliative care research in cancer patients for better health decisions 302
Cochrane Croatia’s collaboration with partner patient/consumer organisations: use of Cochrane evidence, expectations, and opinions on data sharing 303
Methods of mobilizing collective intelligence through crowdsourcing: a scoping review 304
Public and Patient Involvement (PPI) bench to bedside: developing a PPI model across multiple areas of research 305
Rasch analysis of the 9-item Shared Decision Making Questionnaire for women with breast cancer 306
Engaging patients as advisors in systematic reviews: co-building the science to enhance impact and meaning for patients 307
Patient and public involvement in systematic reviews: a systematic review of literature 308
Make evidence-based medicine individualized: synthesizing value-weighted composite endpoints in clinical trials 309
The frequency of patient involvement in clinical practice guideline development in Japan: a descriptive study 310
Treatment decision by patient participation: a preliminary study based on the workpiece of shared decision making in medicine 311
Information needs and information gaps experienced by patients with rare diseases in Poland 312
A survey of patient-centered outcome for coronary heart disease 313
Psychosocial consequences of communicating results of non-invasive prenatal testing to parents: an evidence map 314
A pilot study on the efficacy of shared decision making in nutritional consultant clinics for patients with diabetes mellitus 315
Engaging with the public to co-produce a framework for involving the public when developing national clinical guidelines or audit 316
Accessing and using information for choosing over-the-counter (OTC) medicines by consumers 317
TRANSFER Approach: including consumers in assessing transferability of review findings 319
The provision of services in the UK for armed forces veterans with post-traumatic stress disorder: a rapid evidence synthesis 320
Reflections on stakeholder engagement in a systematic review of effectiveness: integrating the voice of healthcare users 321
Working with stakeholders to identify evidence gaps: an example from autism 322
Improving Public and Patient Involvement (PPI) in end-of-life care research 323
Addressing co-morbidities of spondyloarthritis through patient organization partnerships 324
Patient participation in clinical decision-making in China: a comparative study of doctors' and patients' attitudes and perceptions 325
Treatment uncertainties in blood donation and blood transfusion: involvement of patients and donors as well as clinicians 326
Patient involvement in a meta-analysis of inter-arm blood pressure difference (INTERPRESS-IPD) – what’s the point? 327
Patient involvement in an assessment of interventions for hyperhidrosis 328
Patient and public involvement: a report on the experiences of Cochrane Vascular 329
Question CF: a James Lind Alliance Priority Setting Partnership in cystic fibrosis shared decision making 330
Production, use, dissemination, and training in Cochrane systematic reviews for patient-centered outcomes and health decision-making in Bangladesh: a scoping review 331
The choice of population and outcomes in neonatal trials on hyperbilirubinaemia: are they relevant? an analysis of Cochrane Neonatal reviews 333
Reflections on the use of a novel framework synthesis approach to complete a rapid review of qualitative evidence 334
Purposive sampling within population groups for qualitative evidence syntheses: methodological lessons from building on previous sampling experiences 336
Nuances in following a qualitative evidence synthesis protocol: refining eligibility criteria and focus during the screening of the updated search 337
Identifying subgroups based on continuous measurements in individual patient data meta-analysis 338
Elucidating the impact of having multiple chronic conditions using systematic review and meta-analysis: the case of preventive statin therapy 340
A comparison of methods for meta-analysis of a small number of studies with binary outcomes 341
Increased risks of false-positive or false-negative findings are common in outcomes graded as high certainty of evidence 342
Addressing problems of non-transportability when combining treatment effects across patient populations in meta-analyses: a causality framework 343
Network meta-analysis of combinations of treatments 344
Using flow to estimate the percentage contribution of studies in network meta-analysis 345
A model for network meta-analysis of rare events 346
Can we use results from a broader study population for conclusions about the treatment effect in a subpopulation of interest? 347
Exploring discrepancies in the findings of 20 systematic reviews addressing the same PICO question: a case study 349
How many sample sizes are sufficient to support high-quality evidence - exemplified by a systematic review of iguratimod for the treatment of rheumatoid arthritis 350
Estimating the parameters to a bivariate random-effects model in test accuracy meta-analysis using standard approaches 351
Cochrane Russia making evidence accessible and advocating for evidence 352
Popularization of Cochrane evidence in Croatia: the Cochrane podcast project 353
'Destaques Cochrane’: an initiative for making Cochrane Reviews more popular among students and health professionals in Brazil 354
Improving the production and content of Cochrane podcasts: a Croatian case study 355
German translation activities for Cochrane content 2014 to 2018: achievements and developments 356
Use of Cochrane nutrition reviews in guidelines: appraising the 'payback' on investing in nutrition evidence synthesis 358
Reporting quality appraisal of clinical practice guidelines on gastric cancer 359
Assessing the risk of bias associated with missing participants in randomized controlled trials: a systematic review and meta-analysis in autologous cell therapy for peripheral arterial disease 360
HIRA’s evidence supports rational decision making 361
A descriptive analysis of non-Cochrane child-relevant systematic reviews published in 2014 362
Frameworks for moving from evidence to decision in clinical practice guideline handbooks: a systematic evaluation study 363
AHRQ EPC pilot projects: improving health systems' access to high quality evidence 364
Comments on Cochrane Reviews: who is commenting and what are they saying? 365
How has increased local accountability in public health decision making changed how local evidence is used? 366
Defining variation in outcome reporting: a review of systematic reviews in women’s and newborns' health 367
Sources of heterogeneity in Cochrane Reviews on HIV 368
Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA-A statement 370
What happens after the HTA analysis? A follow-up study of regional HTA reports conducted 2007-2015 371
The use of composite outcomes in neonatal trials: an analysis of Cochrane Reviews 372
Assessing the completeness and comparability of outcomes in systematic reviews addressing food availability 373
Newspaper reports of promising clinical studies: 15-year follow-up 374
Reporting characteristics of Cochrane Reviews on health policy research 375
Conceptualisation of different types of 'evidence' as used and understood by a broad range of public health stakeholders 376
Generalizability of evidence from randomized controlled trials published in the leading medical journals 377
How many practice guidelines are based on systematic reviews: a cross-sectional study of WHO guidelines 378
Contextualising Informed Health Choices primary school resources for use in different countries 379
Completeness of reporting of exercise training interventions in cancer randomized controlled trials published after 2010 380
The timing of outcome measurement is not usually defined in systematic review protocols registered in PROSPERO 382
Implementation of ROBINS-I in non-randomized studies of interventions that have produced qualitatively conflicting results to randomized studies 383